Regulatory T cells in stem cell transplantation: Main characters or walk-on actors?FOZZA, Claudio; DAZZI, Francesco.Critical reviews in oncology/hematology. 2012, Vol 84, Num 1, pp 18-25, issn 1040-8428, 8 p.Article

The Immunosuppressive Properties of Mesenchymal Stem CellsSIEGEL, Georg; SCHÄFER, Richard; DAZZI, Francesco et al.Transplantation. 2009, Vol 87, Num 9S, issn 0041-1337, S45-S49, SUPConference Paper

Engraftment of allogeneic hematopoietic stem cells requires both inhibition of host-versus-graft responses and 'space' for homeostatic expansionLAYLOR, Ruthline; DEWCHAND, Hamlata; SIMPSON, Elizabeth et al.Transplantation. 2005, Vol 79, Num 11, pp 1484-1491, issn 0041-1337, 8 p.Article

The immunomodulatory properties of mesenchymal stem cellsMARIGO, Ilaria; DAZZI, Francesco.Seminars in immunopathology (Print). 2011, Vol 33, Num 6, pp 593-602, issn 1863-2297, 10 p.Article

Dissection of Effector Pathways in the Host-Versus-Graft Response to Bone Marrow TransplantationLING WENG; ADDEY, Caroline; WARRENS, Anthony N et al.Transplantation. 2008, Vol 86, Num 9, pp 1311-1314, issn 0041-1337, 4 p.Article

The role of mesenchymal stem cells in haemopoiesisDAZZI, Francesco; RAMASAMY, Rajesh; GLENNIE, Sarah et al.Blood reviews. 2006, Vol 20, Num 3, pp 161-171, issn 0268-960X, 11 p.Article

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migrationDONG, Rong; CWYNARSKI, Kate; RIDLEY, Anne et al.Blood. 2003, Vol 101, Num 9, pp 3560-3567, issn 0006-4971, 8 p.Article

The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activityLING WENG; WILLIAMS, Richard O; VIEIRA, Pedro L et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 8, pp 1519-1526, issn 0003-4967, 8 p.Article

Strontium can increase some osteoblasts without increasing hematopoietic stem cellsLYMPERI, Stefania; HORWOOD, Nicole; MARLEY, Stephen et al.Blood. 2008, Vol 111, Num 3, pp 1173-1181, issn 0006-4971, 9 p.Article

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapseMUGHAL, Tariq I; YONG, Agnes; APPERLEY, Jane et al.British journal of haematology. 2001, Vol 115, Num 3, pp 569-574, issn 0007-1048Article

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationCHAIDOS, Aristeidis; PATTERSON, Scott; DAVIS, John et al.Blood. 2012, Vol 119, Num 21, pp 5030-5036, issn 0006-4971, 7 p.Article

Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivoLYMPERI, Stefania; ERSEK, Adel; FERRARO, Francesca et al.Blood. 2011, Vol 117, Num 5, pp 1540-1549, issn 0006-4971, 10 p.Article

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaDAZZI, Francesco; SZYDLO, Richard M; GOLDMAN, John M et al.Blood. 2000, Vol 96, Num 8, pp 2712-2716, issn 0006-4971Article

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycleRAMASAMY, Rajesh; FAZEKASOVA, Henrietta; LAM, Eric W.-F et al.Transplantation. 2007, Vol 83, Num 1, pp 71-76, issn 0041-1337, 6 p.Article

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsGLENNIE, Sarah; SOEIRO, Ines; DYSON, Peter J et al.Blood. 2005, Vol 105, Num 7, pp 2821-2827, issn 0006-4971, 7 p.Article

Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humansJAMES, Edward; CHAI, Jian-Guo; DEWCHAND, Hamlata et al.Blood. 2003, Vol 102, Num 1, pp 388-393, issn 0006-4971, 6 p.Article

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axisVIANELLO, Fabrizio; VILLANOVA, Federica; DAZZI, Francesco et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1081-1089, issn 0390-6078, 9 p.Article

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapyIBRAHIM, Amr R; PALIOMPEIS, Christos; DAZZI, Francesco et al.Blood. 2010, Vol 116, Num 25, pp 5497-5500, issn 0006-4971, 4 p.Article

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responsesKARLSSON, Helen; SAMARASINGHE, Sujith; RINGDEN, Olle et al.Blood. 2008, Vol 112, Num 3, pp 532-541, issn 0006-4971, 10 p.Article

Tcrζ^dim lymphocytes define populations of circulating effector cells that migrate to inflamed tissuesZHANG, Zhuoli; GORMAN, Claire L; ISOMAKI, Pia et al.Blood. 2007, Vol 109, Num 10, pp 4328-4335, issn 0006-4971, 8 p.Article

Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationOLAVARRIA, Eduardo; CRADDOCK, Charles; DAZZI, Francesco et al.Blood. 2002, Vol 99, Num 10, pp 3861-3862, issn 0006-4971Article

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTLBELLANTUONO, Ilaria; LIQUAN GAO; PARRY, Suzanne et al.Blood. 2002, Vol 100, Num 10, pp 3835-3837, issn 0006-4971, 3 p.Article